Synonyms:
Status: Phase 2
Entry Type: Antibody
Molecule Category: UNKNOWN
UNII: 7UWT6B0L2U

Pharmacology

Action Mechanism of Action Reference
BINDING AGENT Interleukin-33 binding agent

Indications

Mesh Heading Maximum Phase Mesh ID Reference
Sinusitis 2 D012852 ClinicalTrials
Dermatitis, Atopic 2 D003876 ClinicalTrials

Cross References

Resources Reference
ChEMBL CHEMBL4297580
FDA SRS 7UWT6B0L2U